Overview
Xianhong Liu practices practicing medicine in Changchun, China.
Their clinical expertise encompasses Lung Cancer, Pleural Effusion, EGFR Positive Lung Cancer, and Small Cell Lung Cancer (SCLC).
They are actively involved in clinical research, co-authoring 12 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Xianhong Liu
Is Xianhong Liu a top-rated expert for Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Xianhong Liu is classified as an Experienced expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Xianhong Liu participate in research or clinical trials?
Yes. Xianhong Liu has published 12 articles and abstracts on conditions like Lung Cancer. You can view a list of Xianhong Liu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- EGFR Positive Lung CancerLiu isExperienced. Learn about EGFR Positive Lung Cancer.
- Lung CancerLiu isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Pleural EffusionLiu isExperienced. Learn about Pleural Effusion.
- Small Cell Lung Cancer (SCLC)